Management of recurrent implantation failure

Obstetrics & Gynaecology

Successful implantation depends on coordinated interactions between the developing embryo and the endometrium, progressing through apposition, adhesion, and invasion. Failure at any stage may prevent pregnancy establishment, even when embryo transfer has been technically successful. Recurrent implantation failure (RIF) describes repeated unsuccessful implantation following assisted reproductive treatment, particularly in vitro fertilisation (IVF), although its definition varies across clinical settings. Contemporary approaches emphasise the individual likelihood of implantation, considering factors such as maternal age, embryo characteristics, and the number of embryos transferred. Management requires a structured, evidence-based assessment of potentially relevant factors, including embryo quality, uterine anatomy, endometrial conditions, and selected endocrine or reproductive disorders. Investigations and treatment should be guided by clinical findings, avoiding unnecessary procedures and interventions with limited evidence of benefit. Individualised management and realistic counselling are essential to support informed decisions and optimise care for patients experiencing RIF.[1]Defining and evaluating recurrent implantation failureIndividualized definition: RIF should be considered in the context of the patient's age, embryo developmental stage, embryo quality, number of transfers, and estimated cumulative implantation probability rather than a fixed number of failed cycles aloneReview of previous treatment: Clinicians should review stimulation protocols, fertilization outcomes, embryo development, transfer technique, endometrial preparation, and previous pregnancy history to identify potentially modifiable factorsEmbryo-related assessment: Embryonic aneuploidy is an important contributor to implantation failure, particularly with increasing maternal age. Embryo morphology and developmental progression should be reviewed when planning subsequent treatmentUterine assessment: Transvaginal ultrasonography should be used to evaluate uterine anatomy and endometrial features. Saline infusion sonohysterography or hysteroscopy may be appropriate when intrauterine pathology is suspectedEndocrine assessment: Thyroid function and other endocrine investigations should be guided by clinical history, symptoms, and established indications rather than indiscriminate testingOptimizing embryo transfer and endometrial preparationTransfer technique: Embryo transfer should be performed using a standardized, ultrasound-guided technique when appropriate, with attention to catheter placement and avoidance of unnecessary uterine manipulationEndometrial preparation: The endometrium should be assessed in the context of the treatment protocol, including appropriate timing of progesterone exposure and embryo transferProgesterone support: Luteal-phase support with Progesterone should follow the selected IVF protocol, with additional assessment when inadequate exposure or absorption is suspectedEmbryo selection: Embryo selection should incorporate developmental stage, morphology, and relevant clinical factors. Preimplantation genetic testing for aneuploidy may be discussed in selected circumstances, but it should not be presented as a universal solution for RIFTargeted treatment of identified factorsIntrauterine pathology: Endometrial polyps, submucosal fibroids, and intrauterine adhesions should be managed when they are identified and considered relevant to the uterine cavity or implantationHydrosalpinx: When hydrosalpinx is present, appropriate treatment should be considered before further embryo transfer because it can adversely affect IVF outcomesChronic endometritis: Endometrial evaluation may be considered in selected patients based on clinical history and previous findings, with treatment guided by the diagnosisLifestyle and general health: Smoking cessation, optimization of body weight when appropriate, and management of relevant chronic conditions should be incorporated into preconception careAdditional considerations in clinical practiceClinical factorRelevance to managementMaternal ageHelps contextualize embryo aneuploidy risk and expected treatment outcomes.Ovarian reserveSupports counseling about expected ovarian response and future treatment options.Previous pregnancy lossMay indicate the need for a targeted evaluation distinct from the assessment of implantation failure alone.Psychological burdenRepeated unsuccessful transfers can cause substantial distress, making clear communication and supportive counseling important components of care.ConclusionRIF remains a significant challenge in assisted reproductive technology (ART), with successful implantation depending on embryo competence and appropriate synchronisation with the endometrium. Management should follow an individualised, evidence based approach that considers embryo related factors, uterine anatomy, endometrial preparation, and relevant medical conditions. A systematic review of previous treatment cycles can help identify potentially modifiable factors and guide subsequent in vitro fertilisation (IVF) planning. Although advances in molecular biology have expanded understanding of implantation, additional testing and interventions should be considered only when supported by sufficient evidence of clinical benefit. Clear counselling, realistic expectations, and recognition of the emotional burden of repeated unsuccessful treatment are essential to patient centred care.[2]Reference(s):1. Ma J, Gao W, Li D. Recurrent implantation failure: A comprehensive summary from etiology to treatment. Front Endocrinol (Lausanne). 2023;13:1061766. Published 2023 Jan 5. doi:10.3389/fendo.2022.1061766. https://pmc.ncbi.nlm.nih.gov/articles/PMC9849692/2. Barbakadze T, Zhorzholadze T, Kutchukhidze N, Shervashidze M, Charkviani T. Management of Recurrent Implantation Failure and Hereditary Thrombophilia: A Case Report. Cureus. 2024;16(1):e52882. Published 2024 Jan 24. doi:10.7759/cureus.52882. https://pmc.ncbi.nlm.nih.gov/articles/PMC10811411/